1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow IACS-010759: new trials by email Literature Review of IACS-010759 trials Research Report on IACS-010759
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IACS-010759 in Advanced Cancers Oxidative Phosphorylation Inhibitor IACS-010759, Pharmacodynamic Study, Pharmacokinetic Study - Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 | Phase 1 | Completed | M.D. Anderson Cancer Center | 29 | 2017-11-13 | 2020-11-24 |
| Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Oxidative Phosphorylation Inhibitor IACS-010759, Pharmacological Study - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Terminated | M.D. Anderson Cancer Center | 17 | 2016-09-29 | 2023-06-15 |
Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
M.D. Anderson Cancer Center (2)
United States (2)
Marina Konopleva (1) · Timothy A Yap (1)
P30CA016672 (1)